| 000 | 01290 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515202325.0 | ||
| 264 | 0 | _c20100312 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1090-2430 | ||
| 024 | 7 |
_a10.1016/j.expneurol.2009.12.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMosley, R Lee | |
| 245 | 0 | 0 |
_aControl of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders. _h[electronic resource] |
| 260 |
_bExperimental neurology _cMar 2010 |
||
| 300 |
_a1-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAmyotrophic Lateral Sclerosis _xcomplications |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aNeurodegenerative Diseases _xcomplications |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 700 | 1 | _aGendelman, Howard E | |
| 773 | 0 |
_tExperimental neurology _gvol. 222 _gno. 1 _gp. 1-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.expneurol.2009.12.018 _zAvailable from publisher's website |
| 999 |
_c19424572 _d19424572 |
||